2004
DOI: 10.1111/j.1365-2133.2004.06002.x
|View full text |Cite
|
Sign up to set email alerts
|

Topical paricalcitol (19-nor-1alpha,25-dihydroxyvitamin D2) is a novel, safe and effective treatment for plaque psoriasis: a pilot study

Abstract: Once-daily application of paricalcitol ointment was safe and effective for the treatment of plaque psoriasis.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
11
0

Year Published

2005
2005
2020
2020

Publication Types

Select...
6
3
1

Relationship

0
10

Authors

Journals

citations
Cited by 23 publications
(11 citation statements)
references
References 24 publications
0
11
0
Order By: Relevance
“…Vitamin D3 regulates the calcium and phosphorus levels in blood by promoting its absorption through the GI tract. Local administration of vitamin D3 indeed has a positive therapeutic effect on psoriasis [20][21][22]. The presence of phosphorus in the environment would then result in aggravation of psoriatic lesions.…”
Section: Discussionmentioning
confidence: 99%
“…Vitamin D3 regulates the calcium and phosphorus levels in blood by promoting its absorption through the GI tract. Local administration of vitamin D3 indeed has a positive therapeutic effect on psoriasis [20][21][22]. The presence of phosphorus in the environment would then result in aggravation of psoriatic lesions.…”
Section: Discussionmentioning
confidence: 99%
“…1,25(OH) 2 VD 3 can also block cutaneous contact hypersensitivity99, an effect that could be mediated in part by blocking the induction of skin-homing-receptor expression by lymphocytes99. Consistent with its anti-inflammatory role, a 1,25(OH) 2 VD 3 analogue has been successfully used as a therapy for psoriasis135,136. However, it should be pointed out that topical skin application of 1,25(OH) 2 VD 3 also has the potential to trigger allergic dermatitis by increasing T H 2 cell-mediated responses137.…”
Section: Vitamin Metabolites In Immunotherapymentioning
confidence: 99%
“…A double-blind randomized right-left-comparison placebo-controlled study demonstrated a moderate to excellent response in patients receiving the drug [59]. The therapy was found to be well tolerated with no significant changes in calcium or phosphorous levels.…”
Section: New Topical Vitamin D Analoguesmentioning
confidence: 94%